SEARCH

SEARCH BY CITATION

References

  • Annaert W. G., Esselens C., Baert V., Boeve C., Snellings G., Cupers P., Craessaerts K. and De Strooper B. (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579589.
  • Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grunberg J. and Haass C. (1997) Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1, 149159.
  • Berezovska O., Ramdya P., Skoch J., Wolfe M. S., Bacskai B. J. and Hyman B. T. (2003) Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging. J. Neurosci. 23, 45604566.
  • Brou C., Logeat F., Gupta N., Bessia C., LeBail O., Doedens J. R., Cumano A., Roux P., Black R. A. and Israel A. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207216.
  • Citron M., Westaway D., Xia W. et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3, 6772.
  • Davis J. A., Naruse S., Chen H., Eckman C., Younkin S., Price D. L., Borchelt D. R., Sisodia S. S. and Wong P. C. (1998) An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20, 603609.
  • De Jonghe C., Esselens C., Kumar-Singh S., Craessaerts K., Serneels S., Checler F., Annaert W., Van Broeckhoven C. and De Strooper B. (2001) Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10, 16651671.
  • De Strooper B. (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron 38, 912.
  • De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K. and Dotti C. G. (1995) Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14, 49324938.
  • De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K. and Van Leuven F. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387390.
  • De Strooper B., Annaert W., Cupers P. et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518522.
  • Edbauer D., Winkler E., Regula J. T., Pesold B., Steiner H. and Haass C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486488.
  • Esler W. P., Kimberly W. T., Ostaszewski B. L., Ye W., Diehl T. S., Selkoe D. J. and Wolfe M. S. (2002) Activity-dependent isolation of the presenilin–gamma-secretase complex reveals nicastrin and a gamma substrate. Proc. Natl Acad. Sci. USA 99, 27202725.
  • Esselens C., Oorschot V., Baert V. et al. (2004) Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J. Cell Biol. 166, 10411054.
  • Francis R., McGrath G., Zhang J. et al. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 8597.
  • Goutte C. (2002) Genetics leads the way to the accomplices of presenilins. Dev. Cell 3, 67.
  • Hebert S. S., Serneels L., Dejaegere T., Horre K., Dabrowski M., Baert V., Annaert W., Hartmann D. and De Strooper B. (2004) Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol. Dis. 17, 260272.
  • Herreman A., Hartmann D., Annaert W. et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11 87211 877.
  • Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L. and De Strooper B. (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2, 461462.
  • Ida N., Hartmann T., Pantel J., Schroder J., Zerfass R., Forstl H., Sandbrink R., Masters C. L. and Beyreuther K. (1996) Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 271, 22 90822 914.
  • Kimberly W. T., LaVoie M. J., Ostaszewski B. L., Ye W., Wolfe M. S. and Selkoe D. J. (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl Acad. Sci. USA 100, 63826387.
  • Kopan R. and Ilagan M. X. (2004) Gamma-secretase: proteasome of the membrane? Nat. Rev. Mol. Cell Biol. 5, 499504.
  • Kornilova A. Y., Das C. and Wolfe M. S. (2003) Differential effects of inhibitors on the gamma-secretase complex. Mechanistic implications. J. Biol. Chem. 278, 16 47016 473.
  • Lai M. T., Chen E., Crouthamel M. C. et al. (2003) Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. J. Biol. Chem. 278, 22 47522 481.
  • Li Y. M., Lai M. T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M. K., Shi X. P., Yin K. C., Shafer J. A. and Gardell S. J. (2000) Presenilin 1 linked with gamma – secretase activity in the detergent solubilized state. Proc. Natl. Acad. Sci. 97, 61386143.
  • Marambaud P., Wen P. H., Dutt A., Shioi J., Takashima A., Siman R. and Robakis N. K. (2003) A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114, 635645.
  • Michiels F., Van Es H., Van Rompaey L. et al. (2002) Arrayed adenoviral expression libraries for functional screening. Nat. Biotechnol. 20, 11541157.
  • Moehlmann T., Winkler E., Xia X. et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc. Natl Acad. Sci. USA 99, 80258030.
  • Mumm J. S. and Kopan R. (2000) Notch signaling: from the outside in. Dev. Biol. 228, 151165.
  • Nyabi O., Bentahir M., Horre K., Herreman A., Gottardi-Littell N., Van Broeckhoven C., Merchiers P., Spittaels K., Annaert W. and De Strooper B. (2003) Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and nicastrin glycosylation but remain catalytically inactive in the absence of wild type presenilin. J. Biol. Chem. 278, 43 43043 436.
  • Perez-Tur J., Froelich S., Prihar G. et al. (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297301.
  • Qian S., Jiang P., Guan X. M., Singh G., Trumbauer M. E., Yu H., Chen H. Y., Van de Ploeg L. H. and Zheng H. (1998) Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron 20, 611617.
  • Qi-Takahara Y., Morishima-Kawashima M., Tanimura Y. et al. (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J. Neurosci. 25, 436445.
  • Schagger H., Cramer W. A. and Von Jagow G. (1994) Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal. Biochem. 217, 220230.
  • Scheuner D., Eckman C., Jensen M. et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864870.
  • Schroeter E. H., Ilagan M. X., Brunkan A. L. et al. (2003) A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc. Natl Acad. Sci. USA 100, 13 07513 080.
  • Schulz J. G., Annaert W., Vandekerckhove J., Zimmermann P., De Strooper B. and David G. (2003) Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling. J. Biol. Chem. 278, 48 65148 657.
  • Serneels L., Dejaegere T., Craessaerts K. et al. (2005) Differential contribution of the three Aph1 genes to {gamma}-secretase activity in vivo. Proc. Natl Acad. Sci. USA 102, 17191724.
  • Shah S., Lee S. F., Tabuchi K., Hao Y. H., Yu C., LaPlant Q., Ball H., Dann C. E. 3rd, Sudhof T. and Yu G. (2005) Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122, 435447.
  • Shirotani K., Edbauer D., Prokop S., Haass C. and Steiner H. (2004) Identification of distinct gamma-secretase complexes with different APH-1 variants. J. Biol. Chem. 279, 41 34041 345.
  • Song W., Nadeau P., Yuan M., Yang X., Shen J. and Yankner B. A. (1999) Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl Acad. Sci. USA 96, 69596963.
  • Steiner H., Duff K., Capell A. et al. (1999) A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. J. Biol. Chem. 274, 28 66928 673.
  • Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G. and Iwatsubo T. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422, 438441.
  • Tian G., Ghanekar S. V., Aharony D., Shenvi A. B., Jacobs R. T., Liu X. and Greenberg B. D. (2003) The mechanism of gamma-secretase: multiple inhibitor binding sites for transition state analogs and small molecule inhibitors. J. Biol. Chem. 278, 28 96828 975.
  • Wiltfang J., Esselmann H., Cupers P. et al. (2001) Elevation of beta-amyloid peptide 2–42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. J. Biol. Chem. 276, 42 64542 657.
  • Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. and Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513517.
  • Zhao G., Mao G., Tan J., Dong Y., Cui M. Z., Kim S. H. and Xu X. (2004) Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein. J. Biol. Chem. 279, 50 64750 650.